GE HealthCare Technologies Inc.

Q4 2025 derived revenue: FY2025 ~$20,854M - 9M 2025 $14,927M = ~$5,927M. Seasonally strongest quarter. The FY2025 10-K now describes the company as 'a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases.' AI has been elevated to a primary pillar of the company identity, equal footing with medical technology and pharmaceutical diagnostics. The company employs ~54,000 colleagues with ~9,700 sales and ~8,900 field service engineers. Increased to 4.5% reflecting the year-end ramp in CareIntellect enterprise subscriptions, expanding AI algorithm portfolio, growing AI-enabled equipment install base, and increasing customer willingness to pay premium for AI-powered diagnostic tools. Still no explicit AI revenue figure reported. Math: ~$267M estimated AI / ~$5,927M total = ~4.5%.